Department of Bioengineering, University of Texas at Arlington, Arlington, TX, 76010, USA.
Joint Biomedical Engineering Program, University of Texas Southwestern, Dallas, TX, 75235, USA.
Small. 2018 Aug;14(32):e1800644. doi: 10.1002/smll.201800644. Epub 2018 Jun 27.
Peripheral arterial disease (PAD) is defined as a slow, progressive disorder of the lower extremity arterial vessels characterized by chronic narrowing that often results in occlusion and is associated with loss of functional capacity. Although the PAD occurrence rate is increasing in the elderly population, outcomes with current treatment strategies are suboptimal. Hence, there is an urgent need to develop new technologies that overcome limitations of traditional modalities for PAD detection and therapy. In this Review, the application of nanotechnology as a tool that bridges the gap in PAD diagnosis and therapy is in focus. Several materials including synthetic, natural, biodegradable, and biocompatible materials are used to develop nanoparticles for PAD diagnostic and/or therapeutic applications. Moreover, various recent research approaches are being explored to diagnose PAD through multimodality imaging with different nanoplatforms. Further efforts include targeted delivery of various therapeutic agents using nanostructures as carriers to treat PAD. Last, but not least, despite being a fairly new field, researchers are exploring the use of nanotheranostics for PAD detection and therapy.
外周动脉疾病(PAD)定义为下肢动脉血管的慢性进行性疾病,其特征为慢性狭窄,常导致闭塞,并与功能丧失有关。尽管老年人中的 PAD 发生率正在增加,但目前治疗策略的效果并不理想。因此,迫切需要开发新技术来克服传统 PAD 检测和治疗方法的局限性。在这篇综述中,重点介绍了纳米技术作为一种在 PAD 诊断和治疗中弥合差距的工具的应用。几种材料,包括合成的、天然的、可生物降解的和生物相容的材料,被用于开发用于 PAD 诊断和/或治疗应用的纳米颗粒。此外,正在探索各种新的研究方法,通过不同的纳米平台进行多模态成像来诊断 PAD。进一步的努力包括使用纳米结构作为载体靶向递送各种治疗剂来治疗 PAD。最后但并非最不重要的是,尽管是一个相当新的领域,研究人员正在探索使用纳米治疗学进行 PAD 的检测和治疗。